Brain mitochondrial dysfunction in aging, neurodegeneration, and Parkinson's disease

Frontiers in Aging Neuroscience

Volumn 2, Issue SEP, 2010, Pages

  Navarro, Ana ^a   Boveris, Alberto ^b  

^a UNIVERSITY OF CÁDIZ   (Spain)

^b UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

Antioxidant therapy; Complex I syndrome; Mitochondria targeted antioxidants; Vitamin E

Indexed keywords

EID: 79955646829     PISSN: None     EISSN: 16634365     Source Type: Journal    
DOI: 10.3389/fnagi.2010.00034     Document Type: Review

References (92)

1. Beckman, K. B., and Ames, B. N. (1998). The free radical theory of aging matures. Physiol. Rev. 78, 547-581.
2. Bickford, P. C., Shukitt-Hale, B., and Joseph, J. (1999). Effects of aging on cerebellar noradrenergic function and motor learning: nutritional interventions. Mech. Ageing Dev. 111, 141-154.
3. Bjelakovic, G., Nikolova, D., Gluud, L. L., Simonetti, R. G., and Gluud, C. (2007). Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: systematic review and meta-analysis. JAMA 297, 842-857.
4. Bougria, M., Vitorica, J., Cano, J., and Machado, A. (1995). Implication of dopamine transporter system on 1-methyl-4-phenylpyridinium and rotenone effect in striatal synaptosomes. Eur. J. Pharmacol. 291, 407-415.
5. Boveris, A., and Cadenas, E. (2000). Mitochondrial production of hydrogen peroxide regulation by nitric oxide and the role of ubisemiquinone. IUBMB Life 50, 245-250.
6. Boveris, A., and Chance, B. (1973). The mitochondrial generation of hydrogen peroxide. General properties and effect of hyperbaric oxygen. Biochem. J. 134, 707-716.
7. Boveris, A., and Navarro, A. (2008a). Brain mitochondrial dysfunction in aging. IUBMB Life 60, 308-314.
8. Boveris, A., and Navarro, A. (2008b). Systemic and mitochondrial adaptive responses to moderate exercise in rodents. Free Radic. Biol. Med. 44, 224-229.
9. Boveris, A., and Stoppani, A. O. (1971). Inhibition of mitochondrial swelling by 19-nor-ethynyltestosterone acetate and other steroids. Arch. Biochem. Biophys. 142, 150-156.
10. Boveris, A., Valdez, L. B., Zaobornyj, T., and Bustamante, J. (2006). Mitochondrial metabolic states regulate nitric oxide and hydrogen peroxide diffusion to the cytosol. Biochim. Biophys. Acta 1757, 535-542.
11. Brown, G. C., and Borutaite, V. (2004). Inhibition of mitochondrial respiratory complex I by nitric oxide, peroxynitrite and S-nitrosothiols. Biochim. Biophys. Acta 1658, 44-49.
12. Carreras, M. C., Franco, M. C., Peralta, J. G., and Poderoso, J. J. (2004). Nitric oxide, complex I, and the modulation of mitochondrial reactive species in biology and disease. Mol. Aspects Med. 25, 125-139.
13. Cassarino, D. S., Halvorsen, E. M., Swerdlow, R. H., Abramova, N. N., Parker, W. D. Jr., Sturgill, T. W., and Bennett, J. P. Jr. (2000). Interaction among mitochondria, mitogen-activated protein kinases, and nuclear factor-kappaB in cellular models of Parkinson's disease. J. Neurochem. 74, 1384-1392.
14. Chagnon, P., Betard, C., Robitaille, Y., Cholette, A., and Gauvreau, D. (1995). Distribution of brain cytochrome oxidase activity in various neurodegenerative diseases. Neuroreport 6, 711-715.
15. Chance, B., Sies, H., and Boveris, A. (1979). Hydroperoxide metabolism in mammalian organs. Physiol. Rev. 59, 527-605.
16. Chowanadisai, W., Bauerly, K. A., Tchaparian, E., Wong, A., Cortopassi, G. A., and Rucker, R. B. (2010). Pyrroloquinoline quinone stimulates mitochondrial biogenesis through cAMP response element-binding protein phosphorylation and increased PGC-1alpha expression. J. Biol. Chem. 285, 142-152.
17. Cocco, T., Sgobbo, P., Clemente, M., Lopriore, B., Grattagliano, I., Di, P. M., and Villani, G. (2005). Tissue-specific changes of mitochondrial functions in aged rats: effect of a long-term dietary treatment with N-acetylcysteine. Free Radic. Biol. Med. 38, 796-805.
18. Cutler, R. G. (1991). Antioxidants and aging. Am. J. Clin. Nutr. 53: 373S-379S.
19. Dawson, T. M., and Dawson, V. L. (2003). Molecular pathways of neurodegeneration in Parkinson's disease. Science 302, 819-822.
20. Dennis, J., and Bennett, J. P. Jr. (2003). Interactions among nitric oxide and Bcl-family proteins after MPP+ exposure of SH-SY5Y neural cells I: MPP+ increases mitochondrial NO and Bax protein. J. Neurosci. Res. 72, 76-88.
21. Elfering, S. L., Sarkela, T. M., and Giulivi, C. (2002). Biochemistry of mitochondrial nitric-oxide synthase. J. Biol. Chem. 277, 38079-38086.
22. Eve, D. J., Nisbet, A. P., Kingsbury, A. E., Hewson, E. L., Daniel, S. E., Lees, A. J., Marsden, C. D., and Foster, O. J. (1998). Basal ganglia neuronal nitric oxide synthase mRNA expression in Parkinson's disease. Brain Res. Mol. Brain Res. 63, 62-71.
23. Fand, I., and McNally, W. P. (1981). Whole-body localization of 14C-tocopheryl acetate in the rat following oral administration. Arch. Int. Pharmacodyn. Ther. 250, 4-17.
24. Gatto, E. M., Riobo, N. A., Carreras, M. C., Chernavsky, A., Rubio, A., Satz, M. L., and Poderoso, J. J. (2000). Overexpression of neutrophil neuronal nitric oxide synthase in Parkinson's disease. Nitric Oxide 4, 534-539.
25. Gerschman, R., Gilbert, D. L., Nye, S. W., Dwyer, P., and Fenn, W. O. (1954). Oxygen poisoning and x-irradiation: a mechanism in common. Science 119, 623-626.
26. Ghafourifar, P., and Richter, C. (1997). Nitric oxide synthase activity in mitochondria. FEBS Lett. 418, 291-296.
27. Gilad, G. M., and Gilad, V. H. (1995). Strain, stress, neurodegeneration and longevity. Mech. Ageing Dev. 78, 75-83.
28. Giulivi, C., Poderoso, J. J., and Boveris, A. (1998). Production of nitric oxide by mitochondria. J. Biol. Chem. 273, 11038-11043.
29. Gomez, C., Bandez, M. J., and Navarro, A. (2007). Pesticides and impairment of mitochondrial function in relation with the parkinsonian syndrome. Front. Biosci. 12, 1079-1093.
30. Gonzalez-Flecha, B., Cutrin, J. C., and Boveris, A. (1993). Time course and mechanism of oxidative stress and tissue damage in rat liver subjected to in vivo ischemia-reperfusion. J. Clin. Invest. 91, 456-464.
31. Good, P. F., Hsu, A., Werner, P., Perl, D. P., and Olanow, C. W. (1998). Protein nitration in Parkinson's disease. J. Neuropathol. Exp. Neurol. 57, 338-342.
32. Hagen, T. M., Ingersoll, R. T., Wehr, C. M., Lykkesfeldt, J., Vinarsky, V., Bartholomew, J. C., Song, M. H. and Ames, B. N. (1998). Acetyl-L-carnitine fed to old rats partially restores mitochondrial function and ambulatory activity. Proc. Natl. Acad. Sci. U.S.A. 95, 9562-9566.
33. Harman, D. (1956). Aging: a theory based on free radical and radiation chemistry. J. Gerontol. 11, 298-300.
34. Harman, D. (2006). Free radical theory of aging: an update: increasing the functional life span. Ann. N. Y. Acad. Sci. 1067, 10-21.
35. Hathcock, J. N., Azzi, A., Blumberg, J., Bray, T., Dickinson, A., Frei, B., Jialal, I., Johnston, C. S., Kelly, F. J., Kraemer, K., Packer, L., Parthasarathy, S., Sies, H. and Traber, M.G. (2005). Vitamins E and C are safe across a broad range of intakes. Am. J. Clin. Nutr. 81, 736-745.
36. Hensley, K., Kotake, Y., Sang, H., Pye, Q. N., Wallis, G. L., Kolker, L. M., Tabatabaie, T., Stewart, C. A., Konishi, Y., Nakae, D. and Floyd, R. A. (2000). Dietary choline restriction causes complex I dysfunction and increased H(2)O(2) generation in liver mitochondria. Carcinogenesis 21, 983-989.
37. Hughes, G., Murphy, M. P., and Ledgerwood, E. C. (2005). Mitochondrial reactive oxygen species regulate the temporal activation of nuclear factor kappaB to modulate tumour necrosis factor-induced apoptosis: evidence from mitochondria-targeted antioxidants. Biochem. J. 389, 83-89.
38. James, A. M., Sharpley, M. S., Manas, A. R., Frerman, F. E., Hirst, J., Smith, R. A., and Murphy, M. P. (2007). Interaction of the mitochondria-targeted antioxidant MitoQ with phospholipid bilayers and ubiquinone oxidoreductases. J. Biol. Chem. 282, 14708-14718.
39. Jauslin, M. L., Meier, T., Smith, R. A., and Murphy, M. P. (2003). Mitochondria-targeted antioxidants protect Friedreich Ataxia fibroblasts from endogenous oxidative stress more effectively than untargeted antioxidants. FASEB J. 17, 1972-1974.
40. Kanai, A. J., Pearce, L. L., Clemens, P. R., Birder, L. A., VanBibber, M. M., Choi, S. Y., de Groat, W. C. and Peterson, J. (2001). Identification of a neuronal nitric oxide synthase in isolated cardiac mitochondria using electrochemical detection. Proc. Natl. Acad. Sci. U.S.A. 98, 14126-14131.
41. Kelso, G. F., Porteous, C. M., Coulter, C. V., Hughes, G., Porteous, W. K., Ledgerwood, E. C., Smith, R. A. and Murphy, M. P. (2001). Selective targeting of a redox-active ubiquinone to mitochondria within cells: antioxidant and antiapoptotic properties. J. Biol. Chem. 276, 4588-4596.
42. Lam, P. Y., Yin, F., Hamilton, R. T., Boveris, A., and Cadenas, E. (2009). Elevated neuronal nitric oxide synthase expression during ageing and mitochondrial energy production. Free Radic. Res. 43, 431-439.
43. Liu, J., Head, E., Gharib, A. M., Yuan, W., Ingersoll, R. T., Hagen, T. M., Cotman, C. W. and Ames, B. N. (2002). Memory loss in old rats is associated with brain mitochondrial decay and RNA/DNA oxidation: partial reversal by feeding acetyl-L-carnitine and/or R-alpha-lipoic acid. Proc. Natl. Acad. Sci. U.S.A. 99, 2356-2361.
44. Liu, Q., Raina, A. K., Smith, M. A., Sayre, L. M., and Perry, G. (2003). Hydroxynonenal, toxic carbonyls, and Alzheimer disease. Mol. Aspects Med. 24, 305-313.
45. Mann, V. M., Cooper, J. M., Krige, D., Daniel, S. E., Schapira, A. H., and Marsden, C. D. (1992). Brain, skeletal muscle and platelet homogenate mitochondrial function in Parkinson's disease. Brain 115 (Pt 2), 333-342.
46. Mattiasson, G., and Sullivan, P. G. (2006). The emerging functions of UCP2 in health, disease, and therapeutics. Antioxid. Redox Signal. 8, 1-38.
47. McNamara, P., Durso, R., and Harris, E. (2007). "Machiavellianism" and frontal dysfunction: evidence from Parkinson's disease. Cogn. Neuropsychiatry 12, 285-300.
48. Mizuno, Y., Ohta, S., Tanaka, M., Takamiya, S., Suzuki, K., Sato, T., Oya, H., Ozawa, T. and Kagawa, Y. (1989). Deficiencies in complex I subunits of the respiratory chain in Parkinson's disease. Biochem. Biophys. Res. Commun. 163, 1450-1455.
49. Mugesh, G., du Mont, W. W., and Sies, H. (2001). Chemistry of biologically important synthetic organoselenium compounds. Chem. Rev. 101, 2125-2179.
50. Murphy, M. P., Echtay, K. S., Blaikie, F. H., Asin-Cayuela, J., Cocheme, H. M., Green, K., Buckingham, J. A, Taylor, E. R., Hurrell, F., Hughes, G., Miwa, S., Cooper, C. E., Svistunenko, D. A., Smith, R. A., and Brand, M. D. (2003). Superoxide activates uncoupling proteins by generating carbon-centered radicals and initiating lipid peroxidation: studies using a mitochondria-targeted spin trap derived from alpha-phenyl-N-tert-butylnitrone. J. Biol. Chem. 278, 48534-48545.
51. Murphy, M. P., and Smith, R. A. (2007). Targeting antioxidants to mitochondria by conjugation to lipophilic cations. Annu. Rev. Pharmacol. Toxicol. 47, 629-656.
52. Navarro, A., and Boveris, A. (2004). Rat brain and liver mitochondria develop oxidative stress and lose enzymatic activities on aging. Am. J. Physiol. Regul. Integr. Comp. Physiol. 287, R1244-R1249.
53. Navarro, A., and Boveris, A. (2007a). Brain mitochondrial dysfunction in aging: conditions that improve survival, neurological performance and mitochondrial function. Front. Biosci. 12, 1154-1163.
54. Navarro, A., and Boveris, A. (2007b). The mitochondrial energy transduction system and the aging process. Am. J. Physiol. Cell Physiol. 292, C670-C686.
55. Navarro, A., and Boveris, A. (2008). Mitochondrial nitric oxide synthase, mitochondrial brain dysfunction in aging, and mitochondria-targeted antioxidants. Adv. Drug Deliv. Rev. 60, 1534-1544.
56. Navarro, A., and Boveris, A. (2009). Brain mitochondrial dysfunction and oxidative damage in Parkinson's disease. J. Bioenerg. Biomembr. 41, 517-521.
57. Navarro, A., Boveris, A., Bandez, M. J., Sanchez-Pino, M. J., Gomez, C., Muntane, G., et al. (2009). Human brain cortex: mitochondrial oxidative damage and adaptive response in Parkinson disease and in dementia with Lewy bodies. Free Radic. Biol. Med. 46, 1574-1580.
58. Navarro, A., Gomez, C., Lopez-Cepero, J. M., and Boveris, A. (2004). Beneficial effects of moderate exercise on mice aging: survival, behavior, oxidative stress, and mitochondrial electron transfer. Am. J. Physiol. Regul. Integr. Comp. Physiol. 286, R505-R511.
59. Navarro, A., Gomez, C., Sanchez-Pino, M. J., Gonzalez, H., Bandez, M. J., Boveris, A. D., and Boveris, A. (2005a). Vitamin E at high doses improves survival, neurological performance, and brain mitochondrial function in aging male mice. Am. J. Physiol. Regul. Integr. Comp. Physiol. 289, R1392-R1399.
60. Navarro, A., Torrejon, R., Bandez, M. J., Lopez-Cepero, J. M., and Boveris, A. (2005b). Mitochondrial function and mitochondria-induced apoptosis in an overstimulated rat ovarian cycle. Am. J. Physiol. Endocrinol. Metab. 289, E1101-E1109.
61. Navarro, A., Lopez-Cepero, J. M., Bandez, M. J., Sanchez-Pino, M. J., Gomez, C., Cadenas, E., Boveris, A. (2008). Hippocampal mitochondrial dysfunction in rat aging. Am. J. Physiol. Regul. Integr. Comp. Physiol. 294, R501-R509.
62. Navarro, A., Sanchez Del Pino, M. J., Gomez, C., Peralta, J. L., and Boveris, A. (2002). Behavioral dysfunction, brain oxidative stress, and impaired mitochondrial electron transfer in aging mice. Am. J. Physiol. Regul. Integr. Comp. Physiol. 282, R985-R992.
63. Navarro, A., Sanchez-Pino, M. J., Gomez, C., Bandez, M. J., Cadenas, E., and Boveris, A. (2007). Dietary thioproline decreases spontaneous food intake and increases survival and neurological function in mice. Antioxid. Redox Signal. 9, 131-141.
64. Nicoletti, V. G., Marino, V. M., Cuppari, C., Licciardello, D., Patti, D., Purrello, V. S., and Stella, A. M. (2005). Effect of antioxidant diets on mitochondrial gene expression in rat brain during aging. Neurochem. Res. 30, 737-752.
65. Nisoli, E., Falcone, S., Tonello, C., Cozzi, V., Palomba, L., Fiorani, M., Pisconti, A., Brunelli, S., Cardile, A., Francolini, M., Cantoni, O., Carruba, M.O., Moncada, S. and Clementi, E. (2004). Mitochondrial biogenesis by NO yields functionally active mitochondria in mammals. Proc. Natl. Acad. Sci. U.S.A. 101, 16507-16512.
66. Poeggeler, B., Durand, G., Polidori, A., Pappolla, M. A., Vega-Naredo, I., Coto-Montes, A., Boker, J., Hardeland, R. and Pucci, B. (2005). Mitochondrial medicine: neuroprotection and life extension by the new amphiphilic nitrone LPBNAH acting as a highly potent antioxidant agent. J. Neurochem. 95, 962-973.
67. Raha, S., and Robinson, B. H. (2000). Mitochondria, oxygen free radicals, disease and ageing. Trends Biochem. Sci. 25, 502-508.
68. Reddy, P. H. (2006). Mitochondrial oxidative damage in aging and Alzheimer's disease: implications for mitochondrially targeted antioxidant therapeutics. J. Biomed. Biotechnol. 2006, 1-13.
69. Reddy, P. H. (2007). Mitochondrial dysfunction in aging and Alzheimer's disease: strategies to protect neurons. Antioxid. Redox Signal. 9, 1647-1658.
70. Riobo, N. A., Clementi, E., Melani, M., Boveris, A., Cadenas, E., Moncada, S., and Poderoso, J. J. (2001). Nitric oxide inhibits mitochondrial NADH: ubiquinone reductase activity through peroxynitrite formation. Biochem. J. 359, 139-145.
71. Riobo, N. A., Schopfer, F. J., Boveris, A. D., Cadenas, E., and Poderoso, J. J. (2002). The reaction of nitric oxide with 6-hydroxydopamine: implications for Parkinson's disease. Free Radic. Biol. Med. 32, 115-121.
72. Sastre, J., Millan, A., Garcia-de-la-Asuncion, J., Pla, R., Juan, G., Pallardo, F. O'Connor, E., Martin, J. A., Droy-Lefaix, M. T. and Vina, J. (1998). A Ginkgo biloba extract (EGb 761) prevents mitochondrial aging by protecting against oxidative stress. Free Radic. Biol. Med. 24, 298-304.
73. Schapira, A. H. (2008). Mitochondria in the aetiology and pathogenesis of Parkinson's disease. Lancet Neurol. 7, 97-109.
74. Schapira, A. H., Cooper, J. M., Dexter, D., Clark, J. B., Jenner, P., and Marsden, C. D. (1990a). Mitochondrial complex I deficiency in Parkinson's disease. J. Neurochem. 54, 823-827.
75. Schapira, A. H., Mann, V. M., Cooper, J. M., Dexter, D., Daniel, S. E., Jenner, P., Clark, J. B. and Marsden, C. D. (1990b). Anatomic and disease specificity of NADH CoQ1 reductase (complex I) deficiency in Parkinson's disease. J. Neurochem. 55, 2142-2145.
76. Serra, J. A., Dominguez, R. O., Marschoff, E. R., Guareschi, E. M., Famulari, A. L., and Boveris, A. (2009). Systemic oxidative stress associated with the neurological diseases of aging. Neurochem. Res. 34, 2122-2132.
77. Sheu, S. S., Nauduri, D., and Anders, M. W. (2006). Targeting antioxidants to mitochondria: a new therapeutic direction. Biochim. Biophys. Acta 1762, 256-265.
78. Skulachev, V. P. (2005). How to clean the dirtiest place in the cell: cationic antioxidants as intramitochondrial ROS scavengers. IUBMB Life 57, 305-310.
79. Skulachev, V. P. (2007). A biochemical approach to the problem of aging: "megaproject" on membrane-penetrating ions. The first results and prospects. Biochemistry (Mosc) 72, 1385-1396.
80. Tolmasoff, J. M., Ono, T., and Cutler, R. G. (1980). Superoxide dismutase: correlation with life-span and specific metabolic rate in primate species. Proc. Natl. Acad. Sci. U.S.A. 77, 2777-2781.
81. Turrens, J. F. (2003). Mitochondrial formation of reactive oxygen species. J. Physiol. 552, 335-344.
82. Valdez, L. B., Alvarez, S., Lores-Arnaiz, S., Schopfer, F., and Boveris, A. (2000). Intramitochondrial reactions of peroxynitrite. Free Radic. Biol. Med. 29, 349-356.
83. Valdez, L. B., Zaobornyj, T., and Boveris, A. (2006). Mitochondrial metabolic states and membrane potential modulate mtNOS activity. Biochim. Biophys. Acta 1757, 166-172.
84. Vatassery, G. T., Adityanjee, A., Quach, H. T., Smith, W. E., Kuskowski, M. A., and Melnyk, D. (2004). Alpha and gamma tocopherols in cerebrospinal fluid and serum from older, male, human subjects. J. Am. Coll. Nutr. 23, 233-238.
85. Vina, J., Sastre, J., Pallardo, F., and Borras, C. (2003). Mitochondrial theory of aging: importance to explain why females live longer than males. Antioxid. Redox Signal. 5, 549-556.
86. Vitorica, J., Clark, A., Machado, A., and Satrustegui, J. (1985). Impairment of glutamate uptake and absence of alterations in the energy-transducing ability of old rat brain mitochondria. Mech. Ageing Dev. 29, 255-266.
87. Walker, J. E. (1992). The NADH:ubiquinone oxidoreductase (complex I) of respiratory chains. Q. Rev. Biophys. 25, 253-324.
88. Zandi, P. P., Anthony, J. C., Khachaturian, A. S., Stone, S. V., Gustafson, D., Tschanz, J. T., Norton, M. C., Welsh-Bohmer, K. A. and Breitner, J. C. (2004). Reduced risk of Alzheimer disease in users of antioxidant vitamin supplements: the Cache County Study. Arch. Neurol. 61, 82-88.
89. Zhao, G. M., Qian, X., Schiller, P. W., and Szeto, H. H. (2003a). Comparison of [Dmt1]DALDA and DAMGO in binding and G protein activation at mu, delta, and kappa opioid receptors. J. Pharmacol. Exp. Ther. 307, 947-954.
90. Zhao, K., Luo, G., Zhao, G. M., Schiller, P. W., and Szeto, H. H. (2003b). Transcellular transport of a highly polar 3+ net charge opioid tetrapeptide. J. Pharmacol. Exp. Ther. 304, 425-432.
91. Zhao, K., Luo, G., Giannelli, S., and Szeto, H. H. (2005). Mitochondria-targeted peptide prevents mitochondrial depolarization and apoptosis induced by tert-butyl hydroperoxide in neuronal cell lines. Biochem. Pharmacol. 70, 1796-1806.
92. Zhao, K., Zhao, G. M., Wu, D., Soong, Y., Birk, A. V., Schiller, P. W., and Szeto, H. H. (2004). Cell-permeable peptide antioxidants targeted to inner mitochondrial membrane inhibit mitochondrial swelling, oxidative cell death, and reperfusion injury. J. Biol. Chem. 279, 34682-34690.